Round Hill Asset Management Organon & Co. Transaction History

Round Hill Asset Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $1,542 - $2,309	-72 Reduced 0.76%	9,373 $220,000
Q4 2022 Feb 10, 2023	SELL	$23.31 - $28.61 $1,631 - $2,002	-70 Reduced 0.74%	9,445 $263,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $3,416 - $5,000	-146 Reduced 1.51%	9,515 $223,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $94 - $116	-3 Reduced 0.03%	9,661 $326,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $716 - $928	-25 Reduced 0.26%	9,664 $294,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1,860 - $2,316	-65 Reduced 0.67%	9,689 $318,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $277,501 - $370,652	9,754 New	9,754 $295,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Round Hill Asset Management, based on Form 13F filings with the SEC.

Stay updated on Round Hill Asset Management with notifications on news.